# Botulinum Toxin in the Palatopharyngeal Muscle for the Treatment of Obstructive Sleep Apnea

> **NCT07399782** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Hospital Felicio Rocho** · enrollment: 20 (estimated)

## Conditions studied

- Sleep Apnea Syndrome, Obstructive
- Sleep Apnea Syndrome (OSAS)
- Sleep Apnea/Hypopnea Syndrome
- Sleep Apnea - Obstructive

## Interventions

- **DRUG:** BOTULINUM TOXIN IN THE PALATOPHARYGEUS MUSCLE

## Key facts

- **NCT ID:** NCT07399782
- **Lead sponsor:** Hospital Felicio Rocho
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-05
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07399782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07399782, "Botulinum Toxin in the Palatopharyngeal Muscle for the Treatment of Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07399782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*